Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AXYS Pharmaceuticals Inc. -- Ignore unavailable to you. Want to Upgrade?

To: Tiger who wrote (364)	12/20/1999 11:58:00 AM
From: bob zagorin	Respond to of 455

AXPH made the company of he day on biospace this morning. C o m p a n y o f T h e D a y Axys Pharmaceuticals, Inc. (South San Francisco, California) Axys Pharmaceuticals is a drug discovery and development company with a proprietary focus in oncology. Axys is building shareholder value through (1) a broad and diversified pipeline of research and development programs partnered with world-class pharmaceutical companies; (2) expansion of a non- partnered research and development franchise in oncology; and (3) the spin out of affiliated businesses that leverage the company?s technologies in order to provide capital for Axys? drug discovery and development programs. Axys? technology-leveraging businesses are: Axys Advanced Technologies, a combinatorial chemistry oriented business; PPGx, a majority owned pharmacogenomics company, and Akkadix, an agricultural biotechnology company. biospace.com